Significant pituitary siderosis is common in transfusion-dependent sickle cell disease

2.

Wood

JC

,

Noetzl

L

,

Hyderi

A

,

Joukar

M

,

Coates

T

,

Mittelman

S

.

Predicting pituitary iron and endocrine dysfunction

.

Ann N Y Acad Sci

.

2010

;

1202

(

1

):

123

-

128

.

3.

Farmaki

K

,

Tzoumari

I

,

Pappa

C

,

Chouliaras

G

,

Berdoukas

V

.

Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major

.

Br J Haematol

.

2010

;

148

(

3

):

466

-

475

.

4.

Vichinsky

E

,

Butensky

E

,

Fung

E

, et al.

Comparison of organ dysfunction in transfused patients with SCD or β thalassemia

.

Am J Hematol

.

2005

;

80

(

1

):

70

-

74

.

5.

Noetzli

LJ

,

Coates

TD

,

Wood

JC

.

Pancreatic iron loading in chronically transfused sickle cell disease is lower than in thalassaemia major

.

Br J Haematol

.

2011

;

152

(

2

):

229

-

233

.

6.

Meloni

A

,

Puliyel

M

,

Pepe

A

,

Berdoukas

V

,

Coates

TD

,

Wood

JC

.

Cardiac iron overload in sickle-cell disease

.

Am J Hematol

.

2014

;

89

(

7

):

678

-

683

.

7.

Inamoto

Y

,

Lee

SJ

.

Late effects of blood and marrow transplantation

.

Haematologica

.

2017

;

102

(

4

):

614

-

625

.

8.

Naoum

FA

,

Espósito

BP

,

Ruiz

LP

, et al.

Assessment of labile plasma iron in patients who undergo hematopoietic stem cell transplantation

.

Acta Haematol

.

2014

;

131

(

4

):

222

-

226

.

9.

Wood

JC

.

Guidelines for quantifying iron overload

.

Hematology

.

2014

;

2014

(

1

):

210

-

215

.

10.

Coates

TD

.

Unchanneling cardiac iron in humans

.

Blood

.

2016

;

128

(

12

):

1538

-

1540

.

11.

De Montalembert

M

,

Ribeil

JA

,

Brousse

V

, et al.

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome

.

PLoS One

.

2017

;

12

(

3

):

e0172147

.